Generex Biotechnology Corp., of Toronto, said its subsidiary Antigen Express Inc. hired John Zinckgraf to accelerate development of a vaccine for pandemic influenza.

Genmab A/S, of Copenhagen, Denmark, appointed Bo Kruse vice president and interim chief financial officer.

Genome Canada, of Ottawa, Ontario, appointed Natalie Dakers, Connie Eaves, Thomas Hudson, Kelvin Ogilvie, Jacques Simard and Ronald Worton to its board.

GenoMed Inc., of St. Louis, appointed Richard Reece, Jack Gruninger and Chris Todd to its business development advisory board.

GlobeImmune Inc., of Denver, appointed Francis Chisari to its scientific advisory board.

ImpactRx Inc., of Mount Laurel, N.J., appointed David Arkowitz to its board.

Inhibitex Inc., of Atlanta, appointed Robert Hamm to its board.

Integrated BioPharma Inc., of Hillside, N.J., appointed Eric Friedman acting chief financial officer.